Europe’s Private Equity Industry During COVID-19 and Beyond
Fundraising in H1 2020 reached €49.2 billion, representing a 4 percent decline compared to 2019.
145 documents
Fundraising in H1 2020 reached €49.2 billion, representing a 4 percent decline compared to 2019.
Global fintech investment across M&A, PE, and VC reached $135.7 billion across 2,693 deals in 2019.
European VC-backed companies raised $7.9B across 804 deals in Q4'19.
Total assets under management invested globally in private markets ballooned to an all-time high of US $6.5 trillion.
The 2018/2019 academic year was a record year for spinout exits from UK universities, with sales of spinout company shares totalling more than £61 million, an increase of 37% from 2017/2018.
The Swedish venture capital market represents 35% of total Nordic exit value and over SEK 35 billion in assets under management.
Greater China accounts for 61% of Asia-Pacific-focused PEVC assets under management, tracked across over 4,600 fund managers and 740 investors.
The estimated $757 billion fresh commitment flows to private capital worldwide in 2018 stands 18% below 2017's record fund raising of $925 billion.
Accel has invested $3.8bn across 225 SaaS companies globally.
Private equity investments in India reached $26.3 billion across approximately 793 deals in 2018, making it the second-highest investment year of the last decade.
Global insurance tech investment reached $2.56 billion in the first three quarters of 2018.
Skatteverket estimated that the proposed exit tax would increase annual Swedish tax revenues by around 1 billion kronor starting 1 January 2020.
India's real GDP growth remained stable at 7.1% in FY 2017, primarily driven by growth in services and manufacturing.
Total disclosed healthcare private equity deal value reached $42.6 billion in 2017 across 265 deals.
Global buyout deal value, including add-ons, grew 19% to $440 billion in 2017, while deal count grew 2% to 3,077 deals.
Stockholm attracted 18% of all European Fintech investments in 2014 and 16% over an 11-year period.
The pilot evaluation analyzed 690 NCI SBIR/STTR Phase II grant awards made between 1998 and 2010.
Asia-Pacific private equity deal value reached an all-time high of $159 billion in 2017, a 41% increase over 2016.
The Navy SBIR/STTR Phase II program provided nearly $2.3 billion in funding across 2,734 contracts to 1,199 small businesses between FY 2000 and 2013.
Total cumulative direct sales generated from the Air Force SBIR/STTR Phase II contracts reached $14,691,776,039 across 2,631 commercialized contracts.
Around 70,000 companies are founded each year in Sweden, but only a fraction are suitable for private equity and business angel investments.
The publication contains XXXIII + 399 pages, 79 illustrations, and 34 tables.
The study by Oliver Thalmann examines the challenges and financing options for young biotechnology companies across 305 pages.
The publication provides an overview and analysis of Reverse Takeover (RTO) transactions as an alternative to classic Initial Public Offerings (IPO) in Switzerland.
The publication is released as Volume 6 of the Swiss Private Equity & Corporate Finance Association series.